Brief: Protara Therapeutics Q1 EPS USD -0.97
02/05/2024 13:00
May 02 (Reuters) - Protara Therapeutics Q1 net income USD -11.095 million. * Q1 income from operations USD -11.851 million * Q1 operating expenses USD 11.851 million
Recent news on Protara Therapeutics
See all newsProtara Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protara Therapeutics Q2 net loss widens on higher expenses
Brief: Protara Therapeutics - Enters Sales Agreement With TD Cowen For Common Stock Offering
Brief: Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses
Protara Therapeutics Q1 net loss widens on higher expenses